Sources | Names Used |
---|---|
CTRPv2 | UNC0638:navitoclax (1:1 mol/mol) |
PharmacoGx | UNC0638:navitoclax (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DAP3 | CTRPv2 | pan-cancer | AAC | -0.23 | 3e-10 |
mRNA | GPATCH4 | CTRPv2 | pan-cancer | AAC | -0.23 | 4e-10 |
mRNA | NUP37 | CTRPv2 | pan-cancer | AAC | -0.23 | 6e-10 |
mRNA | MRPL24 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-09 |
mRNA | THEM4 | CTRPv2 | pan-cancer | AAC | -0.22 | 7e-08 |
mRNA | MRPL9 | CTRPv2 | pan-cancer | AAC | -0.22 | 6e-09 |
mRNA | MTX1 | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-09 |
mRNA | NBPF15 | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-08 |
mRNA | MRPS22 | CTRPv2 | pan-cancer | AAC | -0.21 | 8e-09 |
mRNA | NOB1 | CTRPv2 | pan-cancer | AAC | -0.21 | 8e-08 |